Coronavirus medicine: An arthritis drug could be the answer everyone is looking for

The Chinese government approved Swiss drugmaker Roche's anti-inflammation drug Actemra to treat severe coronavirus symptoms. This comes at a time when countries around the world desperately search for new ways to combat the deadly infection.

You are receiving this email because you signed up at Economictimes.com. In case, you wish to Unsubscribe Click here

THE ECONOMIC TIMES NEWS DIGEST Thu, Mar 05, 2020 | 04:30 PM IST

Dear Reader, here are top stories of the day.

Industry Coronavirus medicine: An arthritis drug could be the answer everyone is looking for The Chinese government approved Swiss drugmaker Roche's anti-inflammation drug Actemra to treat severe coronavirus sy... Now that crypto trade is legal in India, here's what happens next Investors say peer to peer (P2P) cos will see inflow of capital, similar to what has been happening globally. ... Coronavirus impact: Indian auto makers may start getting Chinese supplies soon Chinese suppliers have prioritized shipments to large Indian automakers, industry sources said....

Today's Highlights Nirbhaya Case: Convicts to be hanged on March 20 Yesterday, the Delhi government moved a city court seeking a fresh date for the execution of four convicts, saying th... Chopper scam: ED plea against Saxena's status rejected In a blow for the Enforcement Directorate (ED), a local Court today turned down ED's plea seeking to revoke the "appr... Virus could cost airlines USD 113 bn revenue in 2020 "The turn of events as a result of COVID-19 is almost without precedent," said Alexandre de Juniac, head of the Inter...

News HC dismisses Chanda Kochhar's plea against sacking The Bombay High Court on Thursday dismissed a petition filed by Chanda Kochhar against her termination as the managin... Coronavirus wipes $50 bn off global exports in Feb Citing the China Manufacturing Purchasing Manager's Index (PMI), Pamela Coke-Hamilton, who heads UNCTAD's Division on... The 5 tests to find out if you have Coronavirus Here we try to collate the relevant info on how it is being tested and found out if one has caught the dreaded virus ...

Tech BPOs run work-from-home pilots This will enable them to provide services that are cheaper and one that can be dialled-up or down based on demand. Ex... 2 Covid-19 cases in Hyderabad send IT cos into tizzy Meanwhile, tension eased in Bengaluru after Karnataka medical education minister K Sudhakar announced that all five p... Google Cloud to launch second cloud region in India The new Delhi cloud region will expand Google's existing network which stands at eight regions in the Asia Pacific an...

Wealth EPF interest rate lowered by 15 bps to 8.5% for FY20 The interest rate is a big sentiment booster and any cut may further hit the employee sentiment.... Can NRIs save tax through health insurance bought in India? An NRI is allowed to buy a health insurance policy in India to secure their health as well as that of their family me...

Panache 'No Time To Die' release pushed back 7 months amid coronavirus outbreak; film to hit the screens in Nov The Bond film cost an estimated $200 mn to produce and was due to open in movie theaters from April 2. ... Exclusive: 'At (Birla) home, we're not judged for our feelings' Being able to discuss mental health issues at home helped Birla cope with cricket-related anxiety, giving him the str... Don't fall for the impostor syndrome, find your voice: Women need to become the change they want to see Meena Ganesh feels that women must view themselves as people first, and not allow gender to become an obstacle....

Jobs Productivity in India not at par with global standard, says survey The 'Future of Work – Trends at Work and Workplace' study highlights employer sentiments on the trends that will impa...

Mutual Funds RBI to cut rates soon? What should mutual fund investors do? "The Reserve Bank of India is monitoring global and domestic developments closely and continuously and stands ready t... Time to buy? Mutual funds increase equity play "The fall in the market has made stocks cheap compared to their current fair value which made us increase equity allo...

NRI H-1B visa's denial rate higher for Indian IT cos: Study While the denial rate has dropped slightly to 21 per cent in 2019 from 24 per cent in 2018, the National Foundation f...

RISE Fresh set of VCs from Sequoia, Accel, others quit to become founders Accel, an early backer of Flipkart and Swiggy, estimates that 90% of those who stepped down from the fund ended up st... Former Uber self-driving head declares bankruptcy Levandowski filed for Chapter 11 bankruptcy, enabling him to negotiate debts. He has $50 million to $100 million in e...

Follow Us on ET:

About us|Advertise with us|Feedback|Sitemap|Code of Ethics © 2020 Times Internet Limited. Our mailing address is: Economictimes.com (Times Center), FC - 6, Sector 16 A, Film City, Noida - 201301 Uttar Pradesh, India

To ensure delivery directly to your inbox, please add newsletter@economictimesnews.com to your address book today. If you are having trouble viewing this newsletter, please click here

To unsubscribe or edit your subscriptions please click here